NCT02038517 Cirrhosis, Effects of TRAnsplantation and Diabetes
| NCT ID | NCT02038517 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico |
| Condition | Liver Cirrhosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2013-06 |
| Primary Completion | 2016-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2013-06 with a primary completion date of 2016-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This observational study is aimed at assessing insulin secretion and sensitivity by the use of a mathematical modeling from oral glucose tolerance test in subjects with liver cirrhosis undergoing orthotopic liver transplantation (OLT), before and at various time points after OLT.
Eligibility Criteria
Inclusion Criteria: Subjects with end-stage liver cirrhosis in waiting list for orthotopic liver transplantation at the Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy Exclusion Criteria: * Known diabetes * Cystic fibrosis * Pregnancy
Contact & Investigator
Emanuela Orsi, MD
PRINCIPAL INVESTIGATOR
Endocrinology and Diabetes Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy
Frequently Asked Questions
Who can join the NCT02038517 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Liver Cirrhosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02038517 currently recruiting?
Yes, NCT02038517 is actively recruiting participants. Contact the research team at e.orsi@policlinico.mi.it for enrollment information.
Where is the NCT02038517 trial being conducted?
This trial is being conducted at Milan, Italy.
Who is sponsoring the NCT02038517 clinical trial?
NCT02038517 is sponsored by Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico. The principal investigator is Emanuela Orsi, MD at Endocrinology and Diabetes Unit, Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico, Milan, Italy. The trial plans to enroll 200 participants.